SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that MYQORZO™ (aficamten) is now available for prescription in 5 mg, 10 mg, 15 ...

Lisata regains full development rights to certepetide in the Greater China Region BASKING RIDGE, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata” or the ...

Experience the full interactive Multichannel News Release here: https://www.multivu.com/cytokinetics/9362952-en-cytokinetics-on-track-with-hcm Designed in ...

This chapter samples positions for and against physician assisted suicide. It includes statements in the United Kingdom and the United States of America (California) and makes special note of ...

Abstract: The current automatic speech recognition (ASR) technology has achieved remarkable success, but it is vulnerable to adversarial attacks. To solve the problem that existing adversarial attack ...

Editor’s Note: This post is focused on helping you understand profit and loss statements. This financial statement is used by most small business owners to help assess business profits and losses ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Ready to unlock your full math potential? 🎓Subscribe for clear, fun, and easy-to-follow lessons that will boost your skills, build your confidence, and help you master math like a genius—one step at ...

A forensic breakdown of 12 world-class brand positioning statement examples. Learn the internal strategies that built Apple, Tesla, and Amazon. Based on your profile, your project requires a Strategic ...

COPENHAGEN, Denmark, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (ASND) today announced financial results for the third quarter ended September 30, 2025, and provided a business update.

Chinese approval the last major hurdle before deal can close Beijing requires minimum supply from venture to Chinese clients Deal seen closing before Chilean administration leaves office ...

LEXINGTON, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a ...